#Alzheimer's disease

Researchers at Northwestern Medicine say the extracellular matrix in the hippocampus may become vulnerable as estrogen falls with age, offering a new angle on why women face higher Alzheimer’s risk.

Axsome Therapeutics says the FDA has approved Auvelity for agitation associated with Alzheimer’s disease, a condition the company says affects up to 76% of patients.

An Indiana University School of Medicine team says it has found a new way to read the brain’s energy network patterns, offering a potential window into how Alzheimer’s progresses across the disease spectrum.

A Cell study comparing 190 Alzheimer’s brains with 121 healthy brains found that microglia in Alzheimer’s disease carry recurring mutations in a small set of cancer-driving genes, suggesting some neurodegeneration may be

University of Central Florida researchers report evidence that some movement-related symptoms of Alzheimer's disease may originate outside the brain, a finding that could shift future diagnosis and treatment approaches

Two phase 3 EVOKE(+) trials found that semaglutide did not slow clinical progression in Alzheimer’s disease, despite earlier signals that GLP-1 drugs might help.

A growing body of research suggests that the shingles vaccine does more than prevent a painful rash — it may significantly reduce the risk of dementia, including Alzheimer's disease, and even slow biological aging. The latest studies add to evidence that has been accumulating for years.

Researchers have found that Chlamydia pneumoniae, a widespread bacterium known for causing respiratory infections, can invade the brain and retina where it persists for years, triggering inflammation and amyloid-beta accumulation linked to Alzheimer's disease. The discovery opens new avenues for early detection through retinal imaging and potential antibiotic treatments.

Penn State scientists discover that a nanoscale lattice under the neuron membrane acts as a gatekeeper controlling amyloid-beta accumulation.